ClinicalTrials.govpublic full text
Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
smith-lemli-opitz syndrome, cholesterol, slos, hmg-coa reductase inhibitor, malformation syndrome, mental retardation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 887311
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.